Viewing Study NCT00125294

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-02-22 @ 6:46 PM
Study NCT ID: NCT00125294
Status: COMPLETED
Last Update Posted: 2017-09-25
First Post: 2005-07-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Sublingual Methadone for the Management of Cancer Breakthrough Pain
Sponsor: AHS Cancer Control Alberta
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
None Pain View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cancer pain View
None breakthrough pain View
None methadone View
None dose titration View
None sublingual route of administration View
None Cancer related pain View
None currently taking narcotics View